A review on nanotechnology: Properties, applications, and mechanistic insights of cellular uptake mechanisms

S Khan, S Mansoor, Z Rafi, B Kumari, A Shoaib… - Journal of Molecular …, 2022 - Elsevier
Nanotechnology is a relatively new field of science and technology that studies tiny objects
(0.1–100 nm). Due to various positive attributes displayed by the biogenic synthesis of …

Self-assembling, supramolecular chemistry and pharmacology of amphotericin B: Poly-aggregates, oligomers and monomers

R Fernández-García, JC Muñoz-García… - Journal of Controlled …, 2022 - Elsevier
Antifungal drugs such as amphotericin B (AmB) interact with lipids and phospholipids
located on fungal cell membranes to disrupt them and create pores, leading to cell apoptosis …

Effect of aggregation state on the toxicity of different amphotericin B preparations

R Espada, S Valdespina, C Alfonso, G Rivas… - International Journal of …, 2008 - Elsevier
The aim of this work was to study the effect of aggregation of amphotericin B (AMB) in their
toxicity. The aggregation of AMB depends on different formulation factors such as pH and …

Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals

Q Zia, O Mohammad, MA Rauf, W Khan, S Zubair - Scientific reports, 2017 - nature.com
Biomimetic synthesis of nanoparticles offers a convenient and bio friendly approach to
fabricate complex structures with sub-nanometer precision from simple precursor …

Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations

DR Serrano, L Hernández, L Fleire… - International journal of …, 2013 - Elsevier
Amphotericin B (AmB) is a very effective antifungal and antiparasitic drug with a narrow
therapeutic window. To improve its efficacy/toxicity balance, new controlled release …

Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index

Q Zia, A Azhar, M Amjad Kamal, G Aliev… - Current …, 2016 - ingentaconnect.com
Amphotericin B (AmB)-deoxycholate micellar formulation, Fungizone®, is the drug of choice
for the treatment of unidentified mycotic infections. However, it usage has been marred by …

Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans

Q Zia, AA Khan, Z Swaleha, M Owais - International journal of …, 2015 - Taylor & Francis
In the present study, we developed a self-assembled biodegradable polyglutamic acid
(PGA)-based formulation of amphotericin B (AmB) and evaluated its in vitro antifungal …

Amphotericin B nano-assemblies circumvent intrinsic toxicity and ensure superior protection in experimental visceral leishmaniasis with feeble toxic manifestation

F Jamal, I Altaf, G Ahmed, S Asad, H Ahmad, Q Zia… - Vaccines, 2023 - mdpi.com
In spite of its high effectiveness in the treatment of both leishmaniasis as well as a range of
fungal infections, the free form of the polyene antibiotic amphotericin B (AmB) does not …

Development of dextrin-amphotericin B formulations for the treatment of Leishmaniasis

R Silva-Carvalho, J Fidalgo, KR Melo… - International journal of …, 2020 - Elsevier
The most effective medicines available for the treatment of leishmaniasis, a life-threatening
disease, exhibit serious toxicological issues. To achieve better therapeutic efficiency while …

Pharmacokinetics and tissue distribution of an orally administered mucoadhesive chitosan-coated amphotericin B-Loaded nanostructured lipid carrier (NLC) in rats

JSL Tan, C Roberts, N Billa - Journal of Biomaterials Science …, 2020 - Taylor & Francis
Oral delivery of amphotericin B (AmpB) is desirable because it provides a more patient-
friendly mode of administration compared to the current delivery approach akin with the …